Cargando…

In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis

ABSTRACT: Caseous lymphadenitis (CLA) is an infectious disease that affects goats and sheep causing drastic impacts on milk and meat production and is caused by Corynebacterium pseudotuberculosis. The disease can be prevented through vaccination but currently, vaccines demonstrate limited efficacy c...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva, Mara Thais de Oliveira, de Pinho, Rodrigo Barros, Bezerra, Francisco Silvestre Brilhante, Scholl, Nicole Ramos, Moron, Luiza Domingues, Alves, Mirna Samara Dié, Woloski, Rafael dos Santos, Kremer, Frederico Schmitt, Borsuk, Sibele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497191/
https://www.ncbi.nlm.nih.gov/pubmed/34622335
http://dx.doi.org/10.1007/s00253-021-11619-x
_version_ 1784579901431480320
author Silva, Mara Thais de Oliveira
de Pinho, Rodrigo Barros
Bezerra, Francisco Silvestre Brilhante
Scholl, Nicole Ramos
Moron, Luiza Domingues
Alves, Mirna Samara Dié
Woloski, Rafael dos Santos
Kremer, Frederico Schmitt
Borsuk, Sibele
author_facet Silva, Mara Thais de Oliveira
de Pinho, Rodrigo Barros
Bezerra, Francisco Silvestre Brilhante
Scholl, Nicole Ramos
Moron, Luiza Domingues
Alves, Mirna Samara Dié
Woloski, Rafael dos Santos
Kremer, Frederico Schmitt
Borsuk, Sibele
author_sort Silva, Mara Thais de Oliveira
collection PubMed
description ABSTRACT: Caseous lymphadenitis (CLA) is an infectious disease that affects goats and sheep causing drastic impacts on milk and meat production and is caused by Corynebacterium pseudotuberculosis. The disease can be prevented through vaccination but currently, vaccines demonstrate limited efficacy consequently leading to a need for the development of new ones. Here, we described the in silico development of a new chimeric protein constructed with epitopes identified from the sequences of the genes nanH, pknG, spaC, and sodC, previously described as potential vaccinal targets against C. pseudotuberculosis. The chimera was expressed, purified, and its immunogenicity was evaluated using sera of immunized mice. Results indicate the chimeric protein was able to stimulate antibody production. Additionally, analysis using serum from naturally infected goats showed that the protein is recognized by sera from these animals, indicating the possibility for using this chimera in new diagnostic methods. KEY POINTS: • The chimera was expressed with 52 kDa and a yield of 7 mg/L after purification. • The chimera was recognized by the sera of animals immunized with this formulation. • Chimera reacted with the serum of goats naturally infected with C. pseudotuberculosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11619-x.
format Online
Article
Text
id pubmed-8497191
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-84971912021-10-08 In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis Silva, Mara Thais de Oliveira de Pinho, Rodrigo Barros Bezerra, Francisco Silvestre Brilhante Scholl, Nicole Ramos Moron, Luiza Domingues Alves, Mirna Samara Dié Woloski, Rafael dos Santos Kremer, Frederico Schmitt Borsuk, Sibele Appl Microbiol Biotechnol Biotechnologically Relevant Enzymes and Proteins ABSTRACT: Caseous lymphadenitis (CLA) is an infectious disease that affects goats and sheep causing drastic impacts on milk and meat production and is caused by Corynebacterium pseudotuberculosis. The disease can be prevented through vaccination but currently, vaccines demonstrate limited efficacy consequently leading to a need for the development of new ones. Here, we described the in silico development of a new chimeric protein constructed with epitopes identified from the sequences of the genes nanH, pknG, spaC, and sodC, previously described as potential vaccinal targets against C. pseudotuberculosis. The chimera was expressed, purified, and its immunogenicity was evaluated using sera of immunized mice. Results indicate the chimeric protein was able to stimulate antibody production. Additionally, analysis using serum from naturally infected goats showed that the protein is recognized by sera from these animals, indicating the possibility for using this chimera in new diagnostic methods. KEY POINTS: • The chimera was expressed with 52 kDa and a yield of 7 mg/L after purification. • The chimera was recognized by the sera of animals immunized with this formulation. • Chimera reacted with the serum of goats naturally infected with C. pseudotuberculosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00253-021-11619-x. Springer Berlin Heidelberg 2021-10-08 2021 /pmc/articles/PMC8497191/ /pubmed/34622335 http://dx.doi.org/10.1007/s00253-021-11619-x Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Biotechnologically Relevant Enzymes and Proteins
Silva, Mara Thais de Oliveira
de Pinho, Rodrigo Barros
Bezerra, Francisco Silvestre Brilhante
Scholl, Nicole Ramos
Moron, Luiza Domingues
Alves, Mirna Samara Dié
Woloski, Rafael dos Santos
Kremer, Frederico Schmitt
Borsuk, Sibele
In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis
title In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis
title_full In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis
title_fullStr In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis
title_full_unstemmed In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis
title_short In silico analyses and design of a chimeric protein containing epitopes of SpaC, PknG, NanH, and SodC proteins for the control of caseous lymphadenitis
title_sort in silico analyses and design of a chimeric protein containing epitopes of spac, pkng, nanh, and sodc proteins for the control of caseous lymphadenitis
topic Biotechnologically Relevant Enzymes and Proteins
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497191/
https://www.ncbi.nlm.nih.gov/pubmed/34622335
http://dx.doi.org/10.1007/s00253-021-11619-x
work_keys_str_mv AT silvamarathaisdeoliveira insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis
AT depinhorodrigobarros insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis
AT bezerrafranciscosilvestrebrilhante insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis
AT schollnicoleramos insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis
AT moronluizadomingues insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis
AT alvesmirnasamaradie insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis
AT woloskirafaeldossantos insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis
AT kremerfredericoschmitt insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis
AT borsuksibele insilicoanalysesanddesignofachimericproteincontainingepitopesofspacpkngnanhandsodcproteinsforthecontrolofcaseouslymphadenitis